Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-02-19

FDA Approved: GEMFIBROZIL — Supplemental Application (NorthStar Rx LLC)

View source ↗

Summary

The FDA approved a supplemental application for gemfibrozil by NorthStar Rx LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gemfibrozil (Gemfibrozil)

Snippet

SUPPL AP for GEMFIBROZIL (GEMFIBROZIL)